UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For the
month of December 2010
Commission
File Number: 001-34541
CHINA CORD BLOOD
CORPORATION
(Translation
of registrant’s name into English)
48th
Floor, Bank of China Tower
1 Garden
Road
Central
Hong Kong
S.A.R.
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form 20-F
x Form
40-F o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1): o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): o
Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No
x
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82-_______________.
Other
Events
On December 16, 2010, the China Cord
Blood Corporation (the “Company”) issued a press release (the “Press Release”)
announcing that the Company will hold its annual general meeting of record at
the Company’s Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road,
Central, Hong Kong, at 9:00 p.m. on February 18, 2011 Hong Kong Time (February
18, 2011 8:00 a.m. U.S. Eastern Time). The shareholder record date is
January 12, 2011. A copy of the Press Release is attached hereto as
Exhibit 99.1.
Exhibits
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release, dated December 16, 2010
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| CHINA CORD BLOOD CORPORATION | |||
|
|
By:
|
/s/ Albert Chen | |
| Name: | Albert Chen | ||
| Title: | Chief Financial Officer | ||
Dated:
December 16, 2010
China
Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February
18, 2011
HONG KONG, China, December 16, 2010 -
China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), the
first and largest cord blood banking operator in China, today announced that the
Company will hold its annual general meeting of record at the Company’s Hong
Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at
9:00 p.m. on February 18, 2011 Hong Kong Time (February 18, 2011 8:00 a.m. U.S.
Eastern Time). The shareholder record date is January 12,
2011.
China
Cord Blood Corporation filed its annual report on Form 20-F, including its
audited financial statements for the fiscal year ended March 31, 2010, with the
U.S. Securities and Exchange Commission (the "SEC") on July 16, 2010, and filed
an amendment to its annual report on Form 20-F/A with the SEC on October 20,
2010. CCBC's annual report on Form 20-F and the amendment to the
annual report on Form 20-F/A can be accessed at the Investor Center section of
the Company's website at http://www.chinacordbloodcorp.com, as well as on the
SEC's website at http://www.sec.gov. Shareholders may request a hard
copy of the complete and audited financial statements on Form 20-F free of
charge, by contacting [email protected].
About
China Cord Blood Corporation
China
Cord Blood Corporation is the first and largest cord blood banking operator in
China in terms of geographical coverage and is the only cord blood banking
operator with multiple licenses. Under the current PRC government
regulations, only one licensed cord blood banking operator is permitted to
operate in each licensed region and only seven licenses have been authorized as
of today. China Cord Blood Corporation provides cord blood
collection, laboratory testing, hematopoietic stem cell processing, and stem
cell storage services. For more information, please visit our website
at http://www.chinacordbloodcorp.com.
Safe
Harbor Statement
This
press release contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events,
performance and results of operations, and underlying assumptions and other
statements that are other than statements of historical facts. These statements
are subject to uncertainties and risks including, but not limited to, product
and service demand and acceptance, changes in technology, economic conditions,
the impact of competition and pricing, government regulation, and other risks
contained in statements filed from time to time with the Securities and Exchange
Commission. All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the Company, are expressly qualified by the
cautionary statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events or
circumstances after the date hereof.
For
more information, please contact:
China
Cord Blood Corporation
Ms.
Joeling Law
Tel:
(+852) 3605-8180
Email:
[email protected]
ICR,
LLC
In New
York: Ashley M. Ammon: 1-646-277-1227
In
Beijing: Wen Lei Zheng: +86-10-6583-7510